Literature DB >> 17321191

New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland.

Miguel Coca-Prados1, Julio Escribano.   

Abstract

The discovery in the human ocular ciliary body of glaucoma-associated genes (i.e., MYOC, CYP1B1), neuroendocrine processing enzymes, neuroendocrine peptides, steroid-converting enzymes, glutamate transporters, glutamate-metabolizing enzymes, and anti-angiogenic factors requires a reevaluation of its function on aqueous humor secretion, intraocular pressure and its role in glaucoma. The ciliary body should be considered as a multifunctional and interactive tissue. The intrinsic hypotensive and/or hypertensive biological activities of many of the endocrine peptides released by the ciliary epithelium are best explained within the context of a neuroendocrine system, linking the inflow and the outflow of aqueous humor. This interpretation is consistent with physiological and genetic studies indicating that changes altering the inflow affects intraocular pressure. In the proposed endocrine system, regulatory peptides secreted by the ciliary epithelium may subserve multiple functions in the following: inflow and outflow pathways of aqueous humor, ciliary blood flow, the immune privilege status of the anterior segment and the diurnal circadian rhythms of aqueous humor secretion and intraocular pressure. These previously unsuspected and challenging functions of the ciliary epithelium should be considered when assessing the multifactorial events which lead to the pathophysiology of glaucoma affecting the outflow pathways of aqueous humor. This review highlights published, and ongoing studies on authors' labs supporting neuroendocrine, steroidogenic and glutamatergic features of the ciliary epithelium and the endocrine communication between the inflow and outflow pathways of aqueous humor. We also discuss how glaucoma-associated genes expressed in the ciliary body and their mutant proteins could influence intraocular pressure, contributing to the development of glaucoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321191     DOI: 10.1016/j.preteyeres.2007.01.002

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  43 in total

1.  Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications.

Authors:  José-Daniel Aroca-Aguilar; Francisco Sánchez-Sánchez; Sikha Ghosh; Ana Fernández-Navarro; Miguel Coca-Prados; Julio Escribano
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

Review 2.  Glaucoma management: relative value and place in therapy of available drug treatments.

Authors:  Deepak Sambhara; Ahmad A Aref
Journal:  Ther Adv Chronic Dis       Date:  2014-01       Impact factor: 5.091

3.  Differentially expressed microRNAs in the aqueous humor of patients with exfoliation glaucoma or primary open-angle glaucoma.

Authors:  Michelle D Drewry; Pratap Challa; John G Kuchtey; Iris Navarro; Inas Helwa; Yanzhong Hu; Hongmei Mu; W Daniel Stamer; Rachel W Kuchtey; Yutao Liu
Journal:  Hum Mol Genet       Date:  2018-04-01       Impact factor: 6.150

4.  Aqueous humor phospholipids of DBA/2J and DBA/2J-Gpnmb(+)/SjJ mice.

Authors:  Haiyan Wang; Genea Edwards; Catalina Garzon; Carmen Piqueras; Sanjoy K Bhattacharya
Journal:  Biochimie       Date:  2015-04-02       Impact factor: 4.079

Review 5.  Differential gene expression in glaucoma.

Authors:  Tatjana C Jakobs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

6.  Consequences of Puberty on Efficacy of Intraocular Pressure-Lowering Drugs in Male Dutch-Belted Rabbits.

Authors:  Cassandra L Hays; Kingsley C Okafor; Shan Fan; Robin High; Dhirendra P Singh; Carol B Toris
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

7.  GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure.

Authors:  Tatsuo Itakura; Andrew Webster; Shravan K Chintala; Yuchen Wang; Jose M Gonzalez; J C Tan; Janice A Vranka; Ted Acott; Cheryl Mae Craft; Maria E Sibug Saber; Shinwu Jeong; W Daniel Stamer; Kirill A Martemyanov; M Elizabeth Fini
Journal:  J Ocul Pharmacol Ther       Date:  2019-03-18       Impact factor: 2.671

Review 8.  Control of outflow resistance by soluble adenylyl cyclase.

Authors:  Yong Suk Lee; Alan D Marmorstein
Journal:  J Ocul Pharmacol Ther       Date:  2013-12-09       Impact factor: 2.671

9.  Functional role of proteolytic processing of recombinant myocilin in self-aggregation.

Authors:  José-Daniel Aroca-Aguilar; Francisco Martínez-Redondo; Francisco Sánchez-Sánchez; Miguel Coca-Prados; Julio Escribano
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-20       Impact factor: 4.799

10.  Enhanced inflow and outflow rates despite lower IOP in bestrophin-2-deficient mice.

Authors:  Youwen Zhang; Bryan R Davidson; W Daniel Stamer; Jennifer K Barton; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.